Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Pharvaris N.V. (PHVS), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to tackling rare diseases. Headquartered in Zug, Switzerland, this late-stage biopharmaceutical company..
Auna SA (AUNA), a prominent player in the healthcare sector, operates a network of hospitals and clinics across Mexico, Peru, and Colombia. With its headquarters in Luxembourg, this medical care..
AnaptysBio, Inc. (NASDAQ: ANAB) is capturing the attention of investors with a compelling narrative of innovation in the healthcare sector, specifically in biotechnology. Based in San Diego, California, this clinical-stage..
iRadimed Corporation (NASDAQ: IRMD) stands out as a niche player in the healthcare sector, specializing in MRI-compatible medical devices. With its roots firmly planted in the United States and operational..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a key player in the biotechnology sector, is capturing investor attention with its focus on developing innovative treatments for neurodegenerative diseases and endocrine disorders. With..
CorMedix Inc. (NASDAQ: CRMD) is making waves in the biopharmaceutical sector, capturing investor attention with its significant growth potential. With a market capitalization of $862.55 million, this healthcare-focused company is..
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands as a notable player in the biotechnology sector, with its innovative approach to cell programming. Headquartered in Boston, Massachusetts, Ginkgo Bioworks is at..
Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $1.58..
Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a leader in the biotechnology sector, is making waves with its innovative approach to treating rare diseases. With a market capitalization of $522.62 million, this..
Community Health Systems, Inc. (NYSE: CYH), a prominent player in the U.S. healthcare sector, operates a network of general acute care hospitals. Headquartered in Franklin, Tennessee, the company offers a..
Fulgent Genetics, Inc. (FLGT), a prominent player in the Healthcare sector, particularly in Diagnostics & Research, offers an intriguing investment proposition with a potential upside of 10.63% according to current..
AxoGen, Inc. (NASDAQ: AXGN) stands out in the healthcare sector, specifically within the medical devices industry, by focusing on the niche market of peripheral nerve regeneration and repair. With a..
Definitive Healthcare Corp. (NASDAQ: DH) stands at a critical juncture as it aims to navigate the complexities of the healthcare information services industry. With a modest market capitalization of $346.61..
Altimmune, Inc. (NASDAQ: ALT) is catching the eye of investors with its substantial potential upside of 337.66%, making it a compelling consideration for those interested in the biotechnology sector. As..
Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, is garnering significant attention from the investment community, thanks to its promising pipeline and remarkable revenue growth. Operating within the biotechnology..
LifeMD, Inc. (NASDAQ: LFMD), a frontrunner in the expanding telehealth industry, is garnering attention from investors due to its significant potential upside. With a market capitalization of $328.13 million, LifeMD..
Investors interested in the medical instruments and supplies sector may find STAAR Surgical Company (NASDAQ: STAA) to be a compelling case study in market resilience and strategic positioning. Headquartered in..
Enhabit, Inc. (NYSE: EHAB), a prominent player in the healthcare sector, specializes in providing comprehensive home health and hospice services across the United States. With a market capitalization of $410.09..
Iovance Biotherapeutics, Inc. (IOVA), a prominent player in the biotechnology sector, has been making waves with its promising approach to cancer treatment through cell therapies. With a market capitalization of..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a significant player in the healthcare sector focusing on specialty and generic drug manufacturing, presents a compelling investment opportunity with its anticipated 30.11% upside potential,..
